Long-term Prognosis of Papillary Thyroid Carcinoma
Thyroid World Congress ePoster Library. Kojima T. 06/21/19; 272002; 18
Dr. Tsuyoshi Kojima
Dr. Tsuyoshi Kojima
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)

Background:

Since papillary thyroid carcinoma (PTC) is a slow-growing tumor, there are cases where recurrence and/or metastasis occurs after more than 10 years have passed since the treatment. Although the patients with PTC generally have a good prognosis, it is important to consider the long-term outcome.

Methods:

A retrospective study was conducted on 452 patients with PTC who underwent the initial operation from 1977 to 1996 at our institution. The ratio of males and females was 1:8, the average age at the initial surgery was 52 years, and the mean observation period was 20 years.

Results:

The overall survival rate at 10, 20 and 30 years was 89%, 83%, 67% respectively. The disease-specific survival rate at 10, 20 and 30 years was 97%, 95%, 92% respectively. The death of PTC was 23 cases and distant metastasis was the most prevalent pattern with 14 cases. N1b and over 55 years old influenced the prognosis in the multivariate analysis. The disease-free survival rate at 10, 20 and 30 years was 88%, 81%, and 79% respectively. In 19 cases the first recurrence occurred after 10 years or more after surgery.

Discussion & Conclusion:

This report is a very long-term treatment result at a single institution.

N1b and over 55 years old are significantly influenced the prognosis and it is important to consider the long-term follow-up.

 


Background:

Since papillary thyroid carcinoma (PTC) is a slow-growing tumor, there are cases where recurrence and/or metastasis occurs after more than 10 years have passed since the treatment. Although the patients with PTC generally have a good prognosis, it is important to consider the long-term outcome.

Methods:

A retrospective study was conducted on 452 patients with PTC who underwent the initial operation from 1977 to 1996 at our institution. The ratio of males and females was 1:8, the average age at the initial surgery was 52 years, and the mean observation period was 20 years.

Results:

The overall survival rate at 10, 20 and 30 years was 89%, 83%, 67% respectively. The disease-specific survival rate at 10, 20 and 30 years was 97%, 95%, 92% respectively. The death of PTC was 23 cases and distant metastasis was the most prevalent pattern with 14 cases. N1b and over 55 years old influenced the prognosis in the multivariate analysis. The disease-free survival rate at 10, 20 and 30 years was 88%, 81%, and 79% respectively. In 19 cases the first recurrence occurred after 10 years or more after surgery.

Discussion & Conclusion:

This report is a very long-term treatment result at a single institution.

N1b and over 55 years old are significantly influenced the prognosis and it is important to consider the long-term follow-up.

 


    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings